Pure Global AI
UMIN000050295Enrolling by invitation

Prospective observational study examining the impact of sarcopenia in the treatment of advanced stage lung cancer.

Niigata universityNot ApplicableUniversity Hospital Medical Information Network
VerifiedUniversity Hospital Medical Information Network
Study focus
Disease/Condition
lung cancer
Study type
Observational
Sponsor & location
Primary sponsor
Niigata university
Location
Japan
Timeline & enrollment
Phase
Not Applicable
Start date
Oct 01, 2019
End date
N/A
ICD-10 classifications
Carcinoma in situ: Bronchus and lungSecondary malignant neoplasm of lungMalignant neoplasm of bronchus and lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm: Overlapping lesion of bronchus and lung
Data source
Registry
University Hospital Medical Information Network
Trial ID
UMIN000050295
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for UMIN000050295 through Pure Global AI's free database. This Not Applicable trial is sponsored by Niigata university and is currently Enrolling by invitation. The study focuses on lung cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.